Provided by Tiger Trade Technology Pte. Ltd.

Prelude Therapeutics Inc

6.63
+0.13002.00%
Post-market: 6.690.0600+0.90%19:32 EDT
Volume:519.21K
Turnover:3.44M
Market Cap:528.03M
PE:-9.23
High:6.82
Open:6.56
Low:6.40
Close:6.50
52wk High:6.82
52wk Low:0.9807
Shares:79.64M
Float Shares:4.56M
Volume Ratio:0.67
T/O Rate:11.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7183
EPS(LYR):-1.2929
ROE:-57.73%
ROA:-27.15%
PB:3.95
PE(LYR):-5.13

Loading ...

Aug 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 18, 2024

Major Issues Report

Form 8-K - Current report
Jun 12, 2024

Major Issues Report

Form 8-K - Current report
Jun 07, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Correspondence

Form CORRESP - Correspondence
May 04, 2024

Correspondence

Form CORRESP - Correspondence
May 02, 2024

Correspondence

Form CORRESP - Correspondence
Apr 10, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 11, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]